Search Results - "Grabovska, Yura"
-
1
Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity
Published in Nature communications (28-08-2020)“…Immune-therapy is an attractive alternative therapeutic approach for targeting central nervous system (CNS) tumors and the constituency of the Tumor Immune…”
Get full text
Journal Article -
2
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas
Published in Modern pathology (01-07-2021)“…WHO 2016 classified glioblastomas into IDH-mutant and IDH-wildtype with the former having a better prognosis but there was no study on IDH-mutant primary…”
Get full text
Journal Article -
3
RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t(8;21) and t(3;21) AML
Published in Cell reports (Cambridge) (23-05-2017)“…Acute myeloid leukemia (AML) is a heterogeneous disease caused by mutations in transcriptional regulator genes, but how different mutant regulators shape the…”
Get full text
Journal Article -
4
Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry
Published in Frontiers in oncology (08-12-2022)“…Paediatric-type diffuse high-grade gliomas (PDHGG) are aggressive tumors affecting children and young adults, with no effective treatment. These highly…”
Get full text
Journal Article -
5
Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas
Published in Modern pathology (01-06-2021)“…A Correction to this paper has been published: https://doi.org/10.1038/s41379-021-00802-0…”
Get full text
Journal Article -
6
Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus
Published in Neuro-oncology (Charlottesville, Va.) (15-05-2020)“…Abstract Background Atypical teratoid/rhabdoid tumors (ATRTs) are known to exhibit molecular and clinical heterogeneity even though SMARCB1 inactivation is the…”
Get full text
Journal Article -
7
Translational genomics of malignant rhabdoid tumours: Current impact and future possibilities
Published in Seminars in cancer biology (01-04-2020)“…Malignant Rhabdoid Tumours (MRT) are the quintessential example of an epigenetic cancer. Mutation of a single gene, SMARCB1 or more rarely SMARCA4, is capable…”
Get full text
Journal Article -
8
DIPG-37. TRANSCRIPTIONAL, EPIGENETIC, AND IMMUNOLOGICAL FEATURES OF PAEDIATRIC-TYPE H3 K27-ALTERED DIFFUSE MIDLINE GLIOMAS ORIGINATING FROM DIFFERENT BRAIN LOCATIONS
Published in Neuro-oncology (Charlottesville, Va.) (12-06-2023)“…Abstract Diffuse midline gliomas (DMG) are highly aggressive brain tumours predominantly affecting young children. The main oncogenic driver is the…”
Get full text
Journal Article -
9
-
10
EXTH-41. COMBINED PHARMACOLOGICAL AND GENETIC SCREENING TO IDENTIFY DEPENDENCIES AND COMBINATIONS IN ACVR1-MUTANT DIFFUSE MIDLINE GLIOMA
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Somatic mutations in ACVR1, which encodes the serine/threonine kinase ALK2, are found in 20-25% of DMG-H3K27 patients. Treatment of ACVR1-mutant…”
Get full text
Journal Article -
11
DIPG-40. Combined pharmacological and genetic screening to identify dependencies and combinations in ACVR1-mutant diffuse midline glioma
Published in Neuro-oncology (Charlottesville, Va.) (03-06-2022)“…Abstract Somatic mutations in ACVR1, which encodes the serine/threonine kinase ALK2, are found in 20-25% of DMG-H3K27 patients. Treatment of ACVR1-mutant…”
Get full text
Journal Article -
12
Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma
Published in Brain (London, England : 1878) (12-02-2021)“…Paediatric high-grade gliomas (HGGs) account for the most brain tumour-related deaths in children and have a median survival of 12-15 months. One promising…”
Get full text
Journal Article -
13
-
14
PATH-17. INTRAGENIC COPY NUMBER BREAKPOINT ANALYSIS OF METHYLATION DATA FROM CNS TUMOURS IDENTIFIES NOVEL SUBGROUP-SPECIFIC CANDIDATE FUSION GENE ENRICHMENTS
Published in Neuro-oncology (Charlottesville, Va.) (04-12-2020)“…Abstract Methylation array-based molecular profiling has redefined the classification of brain tumours and now forms an important part of their integrated…”
Get full text
Journal Article -
15
Abstract 2120: Interrogation of regulatory and expression changes in Malignant Rhabdoid Tumours to identify new therapeutic approaches
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Abstract Malignant Rhabdoid Tumors (MRTs) are a textbook model of epigenetic dysregulation within cancer. The biallelic inactivation of a single gene SMARCB1…”
Get full text
Journal Article -
16
-
17
Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development
Published in Cell reports (Cambridge) (02-08-2022)“…Medulloblastoma is currently subclassified into distinct DNA methylation subgroups/subtypes with particular clinico-molecular features. Using RNA sequencing…”
Get full text
Journal Article -
18
Multiomics Analysis of IMiD/CELMoD Resistant Multiple Myeloma Models Uncovers Novel and Targetable Vulnerabilities in the SREBP Lipid Synthesis Pathway
Published in Blood (15-11-2022)Get full text
Journal Article -
19
EPCO-24. MULTI-OMIC PROFILING OF PATIENT-DERIVED SUBCLONES IDENTIFIES AGGRESSIVE CELLULAR SUBPOPULATIONS IN PAEDIATRIC DIFFUSE HIGH GRADE GLIOMAS (PDHGGS)
Published in Neuro-oncology (Charlottesville, Va.) (14-11-2022)“…Abstract Paediatric-type diffuse high-grade gliomas are classified into distinct subgroups based upon their location and defining molecular alterations, with…”
Get full text
Journal Article -
20
The Significance of Clinico-Pathological and Molecular Sub-Groups in Malignant Rhabdoid Tumours
Published 01-01-2020“…Introduction: Malignant Rhabdoid Tumours (MRT) are aggressive early childhood tumours characterised by biallelic inactivation of SMARCB1. Having the potential…”
Get full text
Dissertation